Baicalin confers hepatoprotective effect against alcohol-associated liver disease by upregulating microRNA-205

Int Immunopharmacol. 2022 Jun:107:108553. doi: 10.1016/j.intimp.2022.108553. Epub 2022 Mar 28.

Abstract

Recently, baicalin refers to flavonoid compound extracted from Scutellaria baicalensis Georgi has been indicated to hold promising therapeutic effects in alcohol-associated liver disease (ALD). However, knowledge of the molecular mechanisms for its hepatoprotective effect is still very limited. Evidence exists suggesting potential association between miR-205 and baicalin's function. Bioinformatic analysis and dual luciferase reporter assay were conducted to determine the binding affinity between miR-205 and importinα5. Our findings revealed that baicalin could alleviate ALD by raising the expression of miR-205. Additionally, miR-205 repressed NF-κB signaling pathway activation by binding to importinα5 to relieve ALD. Baicalin inhibited importinα5-mediated NF-κB signaling pathway to protect the liver against alcohol-induced injury, inflammation, oxidative stress and hepatocyte apoptosis. Taken conjointly, baicalin confers hepatoprotective effect against ALD through miR-205-mediated importinα5 inhibition via the NF-κB signaling pathway, highlighting a promising therapeutic target for ALD treatment with the help of traditional Chinese medicine.

Keywords: Alcohol-associated liver disease; Baicalin; Hepatic TG; Importinα5; MicroRNA-205; NF-κB signaling pathway.

MeSH terms

  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Humans
  • Liver Diseases, Alcoholic* / drug therapy
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • NF-kappa B / metabolism

Substances

  • Flavonoids
  • MIRN205 microRNA, human
  • MicroRNAs
  • NF-kappa B
  • baicalin